Episode 7 - Talking Prostate Cancer: Homologous Recombination Repair Gene Mutation Testing in Metastatic Prostate Cancer - Part 1: Rationale for HRRm Testing in Metastatic Prostate Cancer
カートのアイテムが多すぎます
カートに追加できませんでした。
ウィッシュリストに追加できませんでした。
ほしい物リストの削除に失敗しました。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
Episode 7 - Talking Prostate Cancer: Homologous Recombination Repair Gene Mutation Testing in Metastatic Prostate Cancer - Part 1: Rationale for HRRm Testing in Metastatic Prostate Cancer
-
ナレーター：
-
著者：
このコンテンツについて
This is an accredited continuing education series of three (3) podcasts as downloadable audio files (MP3). These certified AMA/ABS/ANCC podcasts will clarify the rationale and best-practice approaches for HRRm testing to guide therapeutic strategies in metastatic prostate cancer. Clinical case scenarios are used to enhance the learning experience and provide practical considerations to achieve improved outcomes among patients.
Launch Date: May 30, 2024
Release Date: May 30, 2024
Expiration Date: April 30, 2025
FACULTY BIO
Andrew Armstrong, MD, ScM, FACP
Professor of Medicine, Surgery, Pharmacology and Cancer Biology
Duke University
Tanya Dorff, MD
Professor of Medicine
City of Hope
This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information at the provided link below prior to listening to this episode.
https://www.practicepointcme.com/CMEHome/talking-prostate-cancer-homologous-recombination-repair-gene-mutation-testing-in-metastatic-prostate-cancer-8